Immunity to Candida albicans: Th1, Th2 cells and beyond. (Q33718345)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10458979%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

review article

1 reference

title

Immunity to Candida albicans: Th1, Th2 cells and beyond (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10458979%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10458979%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

author name string

Romani L

series ordinal

1

1 reference

28 July 2017

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10458979%20AND%20SRC:MED&resulttype=core&format=json

Current Opinion in Microbiology

11 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10458979%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10458979%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

page(s)

363-367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10458979%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10458979%20AND%20SRC:MED&resulttype=core&format=json

A TH1-TH2-like switch in candidiasis: new perspectives for therapy.

11 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

The T cell response against fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Recognition of antigenic clusters of Candida albicans by T lymphocytes from human immunodeficiency virus-infected persons.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Animal Models for Candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Specific and non-specific immunity to Candida albicans a lesson from genetically modified animals

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Importance of beta2-microglobulin in murine resistance to mucosal and systemic candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

1 reference

7 January 2021

Burn-associated Candida albicans infection caused by CD30+ type 2 T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Chronic mucocutaneous candidiasis. I. Altered antigen-stimulated IL-2, IL-4, IL-6 and interferon-gamma (IFN-gamma) production

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Increased serum concentrations of interleukin-10 in patients with hepatosplenic candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Candida albicans: pathogenesis, immunity and host defence

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Genetic basis for protection against experimental vaginal candidiasis by peripheral immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Activation of cytokine genes during primary and anamnestic immune response to inactivated c. albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: evidence for vaginal Th1-type responses following intravaginal challenge with Candida antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

CD4+ T-helper-cell responses in mice with low-level Candida albicans infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Immunogenic and protective Candida albicans constituents

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Defective co-stimulation and impaired Th1 development in tumor necrosis factor/lymphotoxin-alpha double-deficient mice infected with Candida albicans.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Candidiasis in interferon-gamma knockout (IFN-gamma-/-) mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Gamma interferon is not essential in host defense against disseminated candidiasis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Protective immunity in experimental Candida vaginitis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

The importance of CD54 and CD86 costimulation in T cells stimulated with Candida albicans and Dermatophagoides farinae antigens in patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Possible participation of polymorphonuclear cells stimulated by microbial immunomodulators in the dysregulated cytokine patterns of AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Iron overload alters innate and T helper cell responses to Candida albicans in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

The role of antibodies in protection against candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Prospects for the development of fungal vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Allergenicity of acid protease secreted by Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Induction of Protective Th1 Responses toCandida albicansby Antifungal Therapy Alone or in Combination with an Interleukin‐4 Antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Cytokines as therapy for opportunistic fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Combination immunotherapy and antifungal chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

Novel strategies for treating candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2899%2980064-2

7 January 2021

10.1016/S1369-5274(99)80064-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10458979%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference